AVROBIO to Participate in Four Upcoming Investor Conferences in September

Author's Avatar
Aug 31, 2022

AVROBIO%2C+Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that members of its senior management team are scheduled to participate in four upcoming investor conferences: